Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/06/026126
CTRI/2020/06/026126
Not yet recruiting
Phase 2

Comparison Of Two different Doses Of Buprenorphine As An Adjuvant To Ropivacaine In Ultrasonography (USG) Guided Supraclavicular Brachial Plexus Block For Upper Limb Surgeries

Dr Dnyaneshwari Munde0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: W19- Unspecified fall

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: W19- Unspecified fall
Sponsor
Dr Dnyaneshwari Munde
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Dnyaneshwari Munde

Eligibility Criteria

Inclusion Criteria

  • •ASA grade 1 2 3
  • •Wt 45 to 70 kg
  • •Age 18 to 70
  • •Scheduled for upper limb surgeries under Supraclavicular Brachial Plexus Block
  • •Sex male and female

Exclusion Criteria

  • •EXCLUSION CRITERIA
  • •Known allergy to local anesthetics
  • •Infection at the site of block
  • •Peripheral neuropathy
  • •Patients on chronic opioid

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Comparing how two different doses of an additive to bupivacaine heavy modifies the duration of action when used in lower limb surgeriesHealth Condition 1: S899- Unspecified injury of lower leg
CTRI/2022/01/039545Dr Ashik Sreekumar
Not yet recruiting
Not Applicable
Prolongation of duration of Spinal AnaesthesiaHealth Condition 1: O- Medical and Surgical
CTRI/2020/04/024692Dr PSIMS RF
Completed
Not Applicable
Buprenorphine as an adjuvant to levobupivacaine in lumbar plexus block for postoperative pain relief after hip, thigh and knee surgeriesHealth Condition 1: null- Patients posted for hip & thigh surgeries under spinal Anesthesia having ASA Grade I & II
CTRI/2018/01/011437Dr RPGMC Kangra at Tanda90
Recruiting
Phase 4
Efficacy of different doses of Buprenorphine on reduction of withdrawal symptoms, anxiety, depression and suicidal thoughtsOpioid dependency.Mental and behavioral disorders due to use of opioids
IRCT2017071925160N6Shiraz University of Medical Sciences60
Completed
Not Applicable
Comparing the effects of Bupropion and Buprenorphine on the reduction of Methamphetamine cravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine : dependence syndromeF 15.2
IRCT2015010320540N1Vice Chancellor for research of Shiraz University of Medical Sciences60